Cerise James, MD, moderates this podcast presentation by the MAPS Evidence Generation Focus Area Working Group in which Neil Belson, JD, discusses Real World Evidence and its impact, including the significance of Real World Evidence for the pharmaceutical and medical device industry, and how the FDA views Real World Evidence.

The podcast objectives are: To define Real World Evidence, and to demonstrate RWE and its impact to Biotech/Pharma.

To read more about the evolving use of Real World Evidence in regulatory decisions, please see the accompanying Elevate article by podcast authors.